<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Parasitology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Parasitology</JournalTitle>
      <Issn>1735-7020</Issn>
      <Volume>5</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2010</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Therapeutic Effect of Sodium Selenite and Zinc Sulphate as Supplementary with Meglumine Antimoniate( Glucantime&#xAE;) Against Cutaneous Leishmaniasis In BALB/C Mice</title>
    <FirstPage>11</FirstPage>
    <LastPage>19</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>F</FirstName>
        <LastName>Zamani Sorkhroodi</LastName>
        <affiliation locale="en_US">Dept. of Nutrition and Biochemistry, School of Health, Tehran University of Medical Science, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>AM</FirstName>
        <LastName>Alavi Naeini</LastName>
        <affiliation locale="en_US">Dept. of Nutrition and Biochemistry, School of Health, Tehran University of Medical Science, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>AR</FirstName>
        <LastName>Zahraei Ramazani</LastName>
        <affiliation locale="en_US">Dept. of Entomology, School of Health, Tehran University of Medical Science, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>MR</FirstName>
        <LastName>Aghaye Ghazvini</LastName>
        <affiliation locale="en_US">Isfahan Center of Public Health Training and Research, Institute of Public Health Research, Tehran University of Medical Science, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>M</FirstName>
        <LastName>Mohebali</LastName>
        <affiliation locale="en_US">Dept. of Medical Parasitology and Mycology, School of Health, Tehran University of Medical Science, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>SA</FirstName>
        <LastName>Keshavarz</LastName>
        <affiliation locale="en_US">Dept. of Nutrition and Biochemistry, School of Health, Tehran University of Medical Science, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>03</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Successful therapy of leishmaniasis depends on effective cellular immune response. We evaluated the effectiveness of sodium selenite and zinc sulphate as known immunomodulator materials, in combination with Glucantime&#xAE; in treatment of cutaneous leishmaniasis lesions resulting from Leishmania ma&#xAD;jor in susceptible animal model.
&#xD;
Methods: Thirty three female mice weighing 18-20 g at the age of 7-8 week infected with L. major were randomly divided into 3 groups: group1:&#xA0; treated by sodium selenite (0.35 mg/kg for 30 days), group2: treated by zinc sulphate (2 mg/kg for 30 days) and group3: treated by distilled water (0.01 ml/gr body weight for 30 days) as control. All groups received Glucantime&#xAE; as a standard anti- leishmanial agent (60 mg/kg, ip) for 14 days. To assess the results of treatment measurement of lesions size and parasitological tests were done weekly.
&#xD;
Results: The lesion sizes increased continuously in sodium selenite group .Although, in zinc group did not in&#xAD;crease compared to baseline But with considering the time- group interaction there was no significant difference between zinc and control group during this study.&#xA0; There was no difference between lesion sizes and Leishmanial loads in the interventional and control groups, respectively.
&#xD;
Conclusion: Sodium selenite and zinc sulphate at mentioned doses and duration of treatment did not show any treatment effect on cutaneous leishmaniasis caused by L. major in BALB/c mice. Increasing the dose of supplements and considering the follow up period after treatment can help more certain conclusion.</abstract>
    <web_url>https://ijpa.tums.ac.ir/index.php/ijpa/article/view/141</web_url>
    <pdf_url>https://ijpa.tums.ac.ir/index.php/ijpa/article/download/141/140</pdf_url>
  </Article>
</Articles>
